Status:

NOT_YET_RECRUITING

Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy

Lead Sponsor:

Wen-hong Zhang

Collaborating Sponsors:

Shandong Provincial Hospital

First Affiliated Hospital Xi'an Jiaotong University

Conditions:

HBV

HCC

Eligibility:

All Genders

18-80 years

Brief Summary

The goal of this prospective, exploratory, non-intervention, multi-center, real-world study is to investigate the predictive value of HBV pgRNA in the occurrence of long-term outcomes under antiviral ...

Detailed Description

This study is a prospective, exploratory, multi-center, real-world study, with Huashan Hospital as the leading unit. The study includes patients with chronic hepatitis B who have been determined by cl...

Eligibility Criteria

Inclusion

  • CHB defined as positive hepatitis B surface antigen at least 6 months, or HBV-related histological changes within 1 year if HBsAg positive less than 6 months;
  • Age between 18-80 years, gender is not limited;
  • Patients with chronic hepatitis B who have been determined by clinicians to start, or have already taken the first-line treatment {including pegylated interferon \[IFN\] monotherapy, a potent nucleos(t)ide analogue \[NA\] monotherapy, two different potent NAs combination therapy, or NA plus IFN combination therapy;
  • Patient who reads and signs informed consent.

Exclusion

  • Patients with malignancies other than hepatocellular carcinoma.

Key Trial Info

Start Date :

December 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 1 2029

Estimated Enrollment :

5000 Patients enrolled

Trial Details

Trial ID

NCT05965388

Start Date

December 1 2023

End Date

February 1 2029

Last Update

July 28 2023

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

The First Affiliated Hospital of Anhui Medical University

Hefei, Anhui, China, 230022

2

The First Affiliated Hospital of Fujian Medical University

Fuzhou, Fujian, China, 350004

3

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China, 430000

4

Jiangsu Province Hospital

Nanjing, Jiangsu, China, 210000

Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy | DecenTrialz